Tang, Kun
Zhang, Qiao
Peng, Nianchun
Hu, Ying
Xu, Shujing
Zhang, Miao
Wang, Rui
Shi, Lixin
Funding for this research was provided by:
Ministry of Science and Technology (2016YFC0901203)
the ministry of health (201502007)
Article History
Received: 19 September 2020
Accepted: 27 November 2020
First Online: 4 January 2021
Ethics approval and consent to participate
: The present study was part of the baseline survey for the Risk Evaluation of Cancers in Chinese Diabetic Individuals: a longitudinal (REACTION) study. The study protocol was approved by the ethics committees at Guizhou Medical University Affiliated Hospital and informed consent had been obtained from each participant who signed a form before the study.
: Written informed consent for publication was obtained from all participants.
: The authors declare that they have no competing interests